ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2017
[Can 12- instead of 4‑weekly zoledronic acid administration reduce skeletal events in patients with bone metastases?]
Dirk RadesPubMed ↗Publisher ↗
No numbers read from the abstract.